Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UIP Passes Pre-Approval Inspection
The University of Iowa Pharmaceuticals (UIP) received a recommendation of approval from the Kansas city district office of FDA to manufacture and test an aseptically filled, sterile prescription
The University of Iowa Pharmaceuticals (UIP) received a recommendation of approval from the Kansas city district office of FDA to manufacture and test an aseptically filled, sterile prescription
NanoBio Corporation (NanoBio) has received an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to fund vaccine research
Caleco Pharma (Caleco) has initiated the clinical studies of Lamiridosin in collaboration with Puleva Biotech (Puleva) to evaluate the effectiveness of Lamiridosin, a dietary supplement that the company
The US Patent and Trademark Office (USPTO) has issued a notice of allowance to Medicis for its US patent application directed to the use of Solodyn (minocycline HCl,
Dow Polyglycols and Surfactants, a business unit of The Dow Chemical Company will introduce a new variety of Carbowax Sentry Polyethylene Glycol (PEG) which will be available in
Saltigo, a wholly owned subsidiary of the LANXESS specialty chemicals group, has presented its comprehensive range of services connected with the synthesis of active pharmaceutical ingredients at the
Metabolic Solutions Development Company (MSDC) has received a $100,000 grant from the Alzheimer’s Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential
The NIH has awarded 22 grants to Kaiser Permanente researchers in various regional centers, including a $25 million Grand Opportunities grant to conduct genotyping on 100,000 Kaiser Permanente
Fermentation of undigested foods in the colon by its resident bacteria affects not only colonic health (protection against inflammation and tumour formation) but also influences metabolic health. Studying
Sinclair Pharma has completed the acquisition of two dermatology products Flammazine and Flammacerium from Solvay Pharmaceuticals for a total consideration of £17.5 million – reported Pharmacy Choice. The